In vitro diagnostic test for endometrial cancer
MiMARK Diagnostics has raised €5.2M across 2 funding rounds from 8 investors, most recently a Seed round in Nov 2023. Based in Barcelona, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-11-27 | Seed | €4.2M | Canterbury Scientific,CDTI Innvierte,Clave Capital,European Innovation Council (EIC),Inveready,Namarel Ventures+2 more | View deal → |
| 2023-06-08 | Other | €1.0M | Clave Capital,Namarel Ventures,Nara Capital,WA4STEAM | View deal → |
